Back to All Events

2026 Best of ASCO® Minneapolis


  • Four Seasons Minneapolis 245 Hennepin Avenue Minneapolis, MN, 55401 United States (map)

In-Person Access Only | 7.50 CE/CME Credits & MOC Points

Please read: All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $99 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team. Industry representatives—defined as any individual who is employed by, contracted with, owns, or represents a drug, device, diagnostic, or other healthcare-related commercial entity, regardless of clinical credentials or licensure—are not permitted to attend Total Health events as general attendees. Members of industry must contact exhibits@totalhealthoncology.com

Total Health's 2026 Best of ASCO® Minneapolis Conference is an officially licensed Best of ASCO® meeting. This Post ASCO® Review showcases abstracts from highly rated presentations, allowing attendees to engage with the latest research and strategies in oncology education. This accredited meeting will be hosted as an in-person conference only with on-demand access for registered attendees.

 

Program Chairs:
Manish Patel, DO (Masonic Cancer Center)
Naomi Fujioka, MD (Masonic Cancer Center)

Conference Agenda
Saturday, August 1, 2026

8:00 AM
Coffee and Exhibits

8:30 AM
Program Chair Welcome
Naomi Fujioka, MD | Masonic Cancer Center‍ ‍

8:40 AM
Colorectal Cancer

Bennett Caughey, MD | Mass General Brigham

9:10 AM
Non-Colorectal Cancer Surgical Trials
Alexander Stark, MD | Allina Health Cancer Institute

9:40 AM
Breakfast and Exhibits

9:55 AM
Non-CME Breakfast -Abbvie Elahere - Mirvetuximab Soravtansine: A FRα Targeted ADC for Platinum Resistant Ovarian Cancer Brent Anderegg, Medical Science Liaison | AbbVie

10:40 AM
Prostate Cancer
Nicholas Zorko, MD, Ph.D. | Masonic Cancer Center

11:10 AM
Non-Prostate Cancer

Petros Grivas, MD, PhD | University of Washington

11:40 AM
Lunch and Exhibits

11:55 AM
Non-CME Lunch -Abbvie Pivekimab Sunirine-pvzy and Blastic Plasmacytoid Dendridic Cell Neoplasm (BPDCN) - Pivekimab Sunirine-pvzy and Blastic Plasmacytoid Dendridic Cell Neoplasm (BPDCN) 

Kate Retz, MSN RN OCN | AbbVie

12:40 PM
Housekeeping and Survey

12:50 PM
Leukemia

Tara Graff, MD | Mission Cancer + Blood

1:20 PM
Lymphoma
Sanjal Desai, MD | Masonic Cancer Center

1:50 PM
Multiple Myeloma

Natalie Callander, MD | University of Wisconsin Carbone Cancer Center

2:20 PM
Melanoma

Daniel Olson, MD | University of Chicago ‍ ‍

2:50 PM
ADJOURN

Sunday, August 2, 2026

7:30 AM
Coffee and Exhibits

8:00 AM
Program Chair Welcome
Manish Patel, DO | Masonic Cancer Center

8:10 AM
Small Cell Lung Cancer
Manish Patel, DO | Masonic Cancer Center

8:40 AM
Non-Small Cell Lung Cancer
‍ ‍‍ ‍Aditi Singh MD | Minneapolis VA Medical Center

9:10 AM
The Emerging Role of PD-1 × VEGF Bispecific Antibodies in NSCLC
Manish Patel, DO | Masonic Cancer Center

9:30 AM
Breakfast and Exhibits

9:55 AM
Non-CME Breakfast - Regeneron - Bringing the Data to Life: Learnings from Clinical Trials to Clinical Practice on a Treatment Option for Advanced NSCLC

Lukas Delasos, MD | Cleveland Clinic

10:40 AM
Head and Neck Cancer

Steve Powell, MD | Sanford Health

11:10 AM
Sarcomas and Rare Cancers
Scott Okuno, MD | Mayo Clinic

11:40 AM
Lunch and Exhibits

11:55 AM
Non-CME Lunch - Pfizer Breast - Learn About a Treatment Option for Patients With HR+/HER2+ mBC

Sramila Aithal, MD | Alliance Cancer Specialists

12:40 PM
Survivorship
Anne Blaes, MD | Masonic Cancer Center

1:10 PM
Metastatic Breast Cancer
Nikitha Vobugari, MD | Masonic Cancer Center

1:40 PM
Early-Stage Breast Cancer

Hemali Batra- Sharma, MD | University of California San Francisco

2:10 PM
Adjourn

Agenda Subject To Change. All times are CDT.

 
 
Previous
Previous
July 25

2026 Best of ASCO® Indianapolis

Next
Next
August 8

2026 Best of ASCO® Boston